The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM
Pharmacological Research · 2024-01 · 199 · 107015
DOI: 10.1016/j.phrs.2023.107015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2024-01. Verfasst von Xuanlin Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China; Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Pr…. Hauptthemen laut MEDLINE: Checklist, Medicine, Chinese Traditional. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhejiang Chinese Medical University, Science and Technology Program of Zhejiang Province.
Abstract (Originalsprache)
Existing reporting checklists lack the necessary level of detail and comprehensiveness to be used in guidelines on Chinese patent medicines (CPM). This study aims to develop a reporting guidance for CPM guidelines based on the Reporting Items of Practice Guidelines in Healthcare (RIGHT) statement. We extracted information from CPM guidelines, existing reporting standards for traditional Chinese medicine (TCM), and the RIGHT statement and its extensions to form the initial pool of reporting items for CPM guidelines. Seventeen experts from diverse disciplines participated in two rounds of Delphi process to refine and clarify the items. Finally, 18 authoritative consultants in the field of TCM and reporting guidelines reviewed and approved the RIGHT for CPM checklist. We added 16 new items and modified two items of the original RIGHT statement to form the RIGHT for CPM checklist, which contains 51 items grouped into seven sections and 23 topics. The new and revised items are distributed across four sections (Basic information, Background, Evidence, and Recommendations) and seven topics: title/subtitle (one new and one revised item), Registration information (one new item), Brief description of the health problem (four new items), Guideline development groups (one revised item), Health care questions (two new items), Recommendations (two new items), and Rationale/explanation for recommendations (six new items). The RIGHT for CPM checklist is committed to providing users with guidance for detailed, comprehensive and transparent reporting, and help practitioners better understand and implement CPM guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China; Key Laboratory of Chinese Medicine Rheumatology of Zhejiang Province, School of Basic Medical Sciences, Zhejiang Chinese Medical Uni…
- Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, Lanzhou University, L…
- Chinese EQUATOR Centre, Hong Kong Baptist University, the Hong Kong Special Administrative Region of China.
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
- School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Förderung
- Zhejiang Chinese Medical University
- Science and Technology Program of Zhejiang Province
Zitieren
APA
Li, X., Huang, L., Wang, L., Jin, X., Zhou, Q., Ma, Y., Wang, Q., Wang, T., Hu, X., Ye, D., Mao, Y., Xie, Z., Chen, Y., & Wen, C. (2024). The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM. Pharmacological Research, 199, 107015. https://doi.org/10.1016/j.phrs.2023.107015
Vancouver
Li X, Huang L, Wang L, Jin X, Zhou Q, Ma Y, et al. The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM. Pharmacological Research. 2024;199:107015. doi:10.1016/j.phrs.2023.107015
BibTeX
@article{Li2024,
author = {Li, Xuanlin and Huang, Lin and Wang, Liaoyao and Jin, Xin and Zhou, Qi and Ma, Yanfang and Wang, Qi and Wang, Tengyue and Hu, Xuanming and Ye, Ding and Mao, Yingying and Xie, Zhijun and Chen, Yaolong and Wen, Chengping},
title = {The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM},
journal = {Pharmacological Research},
year = {2024},
volume = {199},
pages = {107015},
doi = {10.1016/j.phrs.2023.107015}
}
EUVIMED